NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 962 coverNITRIC OXIDE: NOVEL ACTIONS, DELETERIOUS EFFECTS, AND CLINICAL POTENTIAL Copyright © 2002 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by HON, W. M.
Articles by KHOO, H. E.
Search for Related Content
PubMed
PubMed Citation
Articles by HON, W. M.
Articles by KHOO, H. E.
Annals of the New York Academy of Sciences 962:275-295 (2002)
© 2002 New York Academy of Sciences

Nitric Oxide in Liver Diseases

Friend, Foe, or Just Passerby?

WEI MIN HON, KANG HOE LEE AND HOON ENG KHOO

Departments of Medicine and Biochemistry, National University of Singapore, Singapore

Address for correspondence: Wei Min Hon, Ph.D., Department of Medicine, Faculty of Medicine, National University of Singapore, 10 Kent Ridge Crescent, Singapore, 119260. Voice: (65) 779 5555 ext 2368; fax: (65) 779-4112.
mdchonwm{at}nus.edu.sg
Ann. N.Y. Acad. Sci. 962: 275-295 (2002).

Research on the free radical gas, nitric oxide (NO), during the past twenty years is one of the most rapid growing areas in biology. NO seems to play a part in almost every organ and tissue. However, there is considerable controversy and confusion in understanding its role. The liver is one organ that is clearly influenced by NO. Acute versus chronic exposure to NO has been associated with distinct patterns of liver disease. In this paper we review and discuss the involvement of NO in various liver diseases collated from observations by various researchers. Overall, the important factors in determining the beneficial versus harmful effects of NO are the amount, duration, and site of NO production. A low dose of NO serves to maximize blood perfusion, prevent platelet aggregation and thrombosis, and neutralize toxic oxygen radicals in the liver during acute sepsis and reperfusion events. NO also demonstrates antimicrobial and antiapoptosis properties during acute hepatitis infection and other inflammatory processes. However, in the setting of chronic liver inflammation, when a large sustained amount of NO is present, NO might become genotoxic and lead to the development of liver cancer. Additionally, during prolonged ischemia, high levels of NO may have cytotoxic effects leading to severe liver injury. In view of the various possible roles that NO plays, the pharmacologic modulation of NO synthesis is promising in the future treatment of liver diseases, especially with the emergence of selective NO synthase inhibitors and cell-specific NO donors.

Key Words: nitric oxide • liver diseases • friend or foe




This article has been cited by other articles:


Home page
GutHome page
H Suetsugu, Y Iimuro, T Uehara, T Nishio, N Harada, M Yoshida, E Hatano, G Son, J Fujimoto, and Y Yamaoka
Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury
Gut, June 1, 2005; 54(6): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J.-H. Chen, G. L Tipoe, E. C Liong, H. S. So, K.-M. Leung, W.-M. Tom, P. C. Fung, and A. A Nanji
Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants
Am. J. Clinical Nutrition, September 1, 2004; 80(3): 742 - 751.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
M. Koruk, S. Taysi, M. C. Savas, O. Yilmaz, F. Akcay, and M. Karakok
Oxidative Stress and Enzymatic Antioxidant Status in Patients with Nonalcoholic Steatohepatitis
Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 57 - 62.
[Abstract] [Full Text] [PDF]



footerLeft footerRight